Old Web
English
Sign In
Acemap
>
authorDetail
>
Mary Slomkowski
Mary Slomkowski
Pfizer
Placebo
Psychology
Psychiatry
Disease
Amyloid
3
Papers
196
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Individuals with Early Alzheimer's Disease: Amyloid Imaging Positron Emission Tomography and Safety Results from a Phase 2 Study.
2016
C.H. van Dyck
Carl Sadowsky
G Le Prince Leterme
Kevin Booth
Yahong Peng
Kenneth Marek
Nzeera Ketter
Enchi Liu
Bradley T. Wyman
Nicholas Jackson
Mary Slomkowski
J. M. Ryan
Show All
Source
Cite
Save
Citations (10)
Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden
2012
Alzheimers & Dementia
Bradley T. Wyman
Yahong Peng
Kasia Lobello
George Zubal
Michael J. Ryan
Kenneth Marek
John Seibyl
Mary Slomkowski
Show All
Source
Cite
Save
Citations (0)
Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder: A Placebo-Controlled, Multicenter Study
2004
Journal of Clinical Psychopharmacology
Atul C. Pande
Douglas Feltner
James W. Jefferson
Jonathan R. T. Davidson
Mark H. Pollack
Murray B. Stein
R. Bruce Lydiard
Rise Futterer
Paula Robinson
Mary Slomkowski
Eugene DuBoff
Phelps M
Carol A. Janney
John L. Werth
Show All
Source
Cite
Save
Citations (186)
1